Login to Your Account



Rigel, Merck Joining Efforts To Explore Ubiquitin Ligases

By Randall Osborne


Tuesday, November 16, 2004
Three academic scientists jointly won the 2004 Nobel Prize for research into ubiquitin ligases, and Rigel Pharmaceuticals Inc. is taking home an "award" of its own - a deal with Merck & Co. Inc. to investigate the new class of drugs for cancer therapies and others. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription